Health Industry Manufacturers Association (HIMA) offers advice on Medicare pricing proposals as costly implantables escape new outpatient rules
This article was originally published in Clinica
The Health Care Financing Administration, which administers Medicare, the US health plan for the elderly, has apparently decided to exempt implantable devices from its new cost-containment strategy for hospital outpatient care.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.